$9.40
-7.14-43.17%
Pelthos Therapeutics (PTHS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.96 | $-3.66 | $-4.09 | $-0.67 |
| Actual | $-6.62 | $-3.09 | $-6.87 | $-5.30 |
| Surprise | -123.6% | +15.6% | -68.0% | -691.0% |
| Revenue | ||||
| Estimate | $15.4M | $10.3M | $9.1M | $6.9M |
| Actual | $15.6M | $10.9M | $9.4M | $7.4M |
| Surprise | +1.41% | +5.90% | +3.47% | +7.66% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-3.23 | $-2.81 | $-0.56 | $0.31 |
| Revenue | ||||
| Consensus | $17.2M | $19.1M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-6.62 | $-2.96 | -123.6 % |
| Q1 | May 14, 2026 | $-3.09 | $-3.66 | 15.6 % |
| Q4 | Mar 19, 2026 | $-6.87 | $-4.09 | -68.0 % |
| Q3 | Nov 13, 2025 | $-5.30 | $-0.67 | -691.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $15.60M | $15.39M | 1.41 % |
| Q1 | May 14, 2026 | $10.91M | $10.30M | 5.90 % |
| Q4 | Mar 19, 2026 | $9.39M | $9.07M | 3.47 % |
| Q3 | Nov 13, 2025 | $7.41M | $6.88M | 7.66 % |